Health Care: Drugs

Enanta Pharmaceuticals Inc (ENTA: NASDAQ)

$38.56 -0.88 | -2.23%
09/22/14 - 11:16 AM ET
Company Cash Flow
Sep 2013 Sep 2012 Sep 2011
Cash Flow From Operating Activities
Net Income (Loss) 9.63M 21.40M 23.31M
Operating Gains/Losses -100.00K -63.00K -677.00K
Extraordinary Gains / Losses 0.00 0.00 0.00
(Increase) Decrease In Receivables 1.35M -2.68M -251.00K
(Increase) Decrease in Inventories 0.00 0.00 0.00
(Increase) Decrease In Other Current Assets 0.00 0.00 0.00
(Decrease) Increase In Payables 115.00K 763.00K 58.00K
(Decrease) Increase In Other Current Liabilities -285.00K 1.73M -1.12M
(Increase) Decrease In Other Working Capital -132.00K 520.00K -814.00K
Other Non-Cash Items -1.10M 432.00K 2.97M
Net Cash From Continuing Operations 10.65M 22.62M 24.02M
Net Cash From Discontinued Operations 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities 10.65M 22.62M 24.02M
Sale of Property, Plant & Equipment 0.00 66.00K 9.00K
Cash Used for Investing Activities
Sale of Short-Term Investments 0.00 0.00 0.00
Purchases of Property, Plant & Equipment -606.00K -252.00K -445.00K
Acquisitions 0.00 0.00 0.00
Purchases of Short-Term Investments 0.00 0.00 0.00
Other Cash from Investing Activities 0.00 1.14M -436.00K
Cash Provided by Financing Activities
Net Cash From Investing Activities -69.22M -18.04M -17.68M
Issuance of Debt 0.00 0.00 2.00M
Cash Used for Financing Activities
Issuance of Capital Stock 60.45M 141.00K 34.00K
Repayment of Long-Term Debt 0.00 0.00 -2.00M
Repurchase of Capital Stock 0.00 0.00 0.00
Payment of Cash Dividends 0.00 0.00 0.00
Other Financing Charges, Net -3.54M -1.05M 0.00
Net Cash From Financing Activities 56.91M -909.00K 34.00K
Effect of Exchange Rate Changes 0.00 0.00 0.00
Net Change in Cash & Cash Equivalents -1.65M 3.67M 6.37M

Portfolios with ENTA

Latest ENTA Headlines from TheStreet

More Financial News for ENTA

Press Releases for ENTA

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter